FDA.reportPublic FDA data

selpercatinib 40 MG Oral Capsule [Retevmo]

RxCUI
2370170
RxNorm name
selpercatinib 40 MG Oral Capsule [Retevmo]
Display name
selpercatinib 40 MG Oral Capsule [Retevmo]
Full name
selpercatinib 40 MG Oral Capsule [Retevmo]
Term type
SBD
Status
DailyMed mapping
Updated
2026-06-04 23:39:05

DailyMed RxNorm Mappings#

Set ID, RxNorm string, TTY table
Set IDRxNorm stringTTYSPL versionLabelEffective
7fa848ba-a59c-4144-9f52-64d090f4d828selpercatinib 40 MG Oral Capsule [Retevmo]SBD22These highlights do not include all the information needed to use RETEVMO safely and effectively. See full prescribing information for RETEVMO. RETEVMO ® (selpercatinib) capsules, for oral use RETEVMO ® (selpercatinib) tablets, for oral use Initial U.S. Approval: 202020251120
7fa848ba-a59c-4144-9f52-64d090f4d828Retevmo 40 MG Oral CapsulePSN22These highlights do not include all the information needed to use RETEVMO safely and effectively. See full prescribing information for RETEVMO. RETEVMO ® (selpercatinib) capsules, for oral use RETEVMO ® (selpercatinib) tablets, for oral use Initial U.S. Approval: 202020251120
7fa848ba-a59c-4144-9f52-64d090f4d828Retevmo 40 MG Oral CapsuleSY22These highlights do not include all the information needed to use RETEVMO safely and effectively. See full prescribing information for RETEVMO. RETEVMO ® (selpercatinib) capsules, for oral use RETEVMO ® (selpercatinib) tablets, for oral use Initial U.S. Approval: 202020251120